Tellgen

Tellgen Earnings Yield

The Earnings Yield of Tellgen (300642.SZ) as of Oct 30, 2026 is 0.12 %. In the previous year, Earnings Yield was 1.16 % — a change of -89.61% (lower).

Earnings Yield

0.12 %

YoY

-89.61%

Last updated:

Earnings Yield of Tellgen is 2025 0.12 % . Earnings Yield of Tellgen was 2024 1.16 % . It decreases by -89.61% lower compared to the previous year.

The Tellgen Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2018
4.76 CNY
Jan 1, 2019
5.28 CNY
Jan 1, 2020
4.05 CNY
Jan 1, 2021
5.42 CNY
Jan 1, 2022
4.19 CNY
Jan 1, 2023
3.01 CNY
Jan 1, 2024
1.16 CNY
Jan 1, 2025
0.12 CNY
The Tellgen Earnings Yield history
YEAREarnings YieldYoY
0.12 %-89.61%
1.16 %-61.37%
3.01 %-28.34%
4.19 %-22.55%
5.42 %+33.62%
4.05 %-23.22%
5.28 %+10.82%
4.76 %+11.73%
4.26 %+29.71%
3.29 %+48.63%
2.21 %+82.70%
1.21 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tellgen Stock analysis

What does Tellgen do? Tellgen Corp develops, manufactures, and markets molecular diagnostic products including immunodiagnostic, molecular diagnostic, and biochemical diagnostic products. Their portfolio features tumor marker detection, HPV nucleic acid testing, autoimmune disease detection, and lung cancer methylation mutation detection products. The company targets healthcare providers and laboratories seeking advanced diagnostic solutions for disease detection and monitoring. Tellgen Corp generates revenue through the sale of these specialized diagnostic products to medical institutions and healthcare facilities. The firm's product lines focus on specific diagnostic needs such as cancer screening and infectious disease testing. Immunodiagnostic products detect antibodies and antigens, molecular diagnostic products analyze genetic material, and biochemical diagnostic products measure metabolic markers. Tellgen Corp sells these products directly to hospitals, clinics, and diagnostic laboratories across China and potentially internationally. Tellgen Corp's revenue streams come from the commercialization of its diagnostic product portfolio. The company's offerings address key healthcare challenges including early cancer detection and infectious disease management. Their products are designed to support clinical decision-making and patient care pathways in medical settings. Tellgen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tellgen stock

Earnings Yield of Tellgen is 0.12 % in 2025.

Earnings Yield of Tellgen changed from 1.16 % to 0.12 %, representing a -89.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Tellgen since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Tellgen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Tellgen

All Key Metrics — Tellgen